Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
基本信息
- 批准号:9445426
- 负责人:
- 金额:$ 60.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffectAgeAgingAnimalsAntibiotic TherapyAntibioticsAntibodiesAntitumor ResponseAttenuatedAutophagocytosisBacterial TranslocationCD4 Positive T LymphocytesCD8B1 geneClinical ManagementClinical TrialsCombined Modality TherapyCytotoxic T-Lymphocyte-Associated Protein 4DataDendritic CellsDevelopmentFoundationsGlutamineGrowthHousingImmuneImpairmentInfiltrationLifeLigandsLinkMalignant NeoplasmsMediator of activation proteinMetabolismModalityModelingMonitorMouse StrainsMucous MembraneMusMyelogenousMyeloid CellsOutcomePDCD1LG1 genePatientsPhenotypePhysiologicalPlayPredispositionRegulationRoleSLEB2 geneSmall IntestinesStressT cell regulationT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTumor-Infiltrating LymphocytesVolatile Fatty Acidsbacteriomebasegut microbiomegut microbiotaimmune checkpointimprovedinsightlymph nodesmacrophagemelanomamicrobiomemicrobiome compositionmicrobiotamicrobiota profilesmigrationmutantnovelnovel therapeuticspatient stratificationreceptorresponsesextargeted treatmenttumortumor growthtumor microbiometumor microenvironmentubiquitin ligase
项目摘要
Project Summary
This application is set to define a novel mechanism underlying the control of gut microbiota-immune checkpoint
interactions by the ubiquitin ligase RNF5, and the implications of such regulation to melanoma development
and response to therapy. Despite the most exciting and significant advances made in clinical management of
melanoma via the immune-checkpoint based clinical trials, mechanisms underlying their control, the
susceptibility to distinct therapies (or not), are among the fundamental questions that remain unsolved. Here,
we provide data to support a model whereby immune checkpoints are regulated by gut microbiome, which is
defined by the ubiquitin ligase RNF5. Our discovery of impaired growth of Braf/Pten mutant melanoma in
syngeneic Rnf5–/– mice, compared with Rnfwt littermates, was linked with enhanced infiltration of tumor-
infiltrating lymphocytes (TILs) (CD4 and CD8 positive), macrophages and dendritic cells in the tumors that
developed significantly slower in the Rnf5–/– mice. Strikingly, co-housing the Rnf5–/– and Rnfwt animals or
antibiotic ablation of the gut microbiota resulted in loss of the above phenotypes—tumor growth was no longer
attenuated and immune checkpoint-based phenotypes were largely lost. Assessment of the gut microbiome
revealed a distinct subset of bacterial species, which distinguish Rnf5–/– mice from their WT littermates (all
“pure” in-house maintained C57BL/6 strain). Notably, common to the distinct RNF5-microbiome are bacterial
species that generate select subset of short chain fatty acids. These observations provide the foundation for
our hypothesis that RNF5 controls the intestinal microbiota that affects immune checkpoint
mechanisms, which in turn impacts melanoma development. Our proposed studies will (i) define RNF5
effect on the gut microbiome–tumor interactions, (ii) identify microbiome-dependent changes in the regulation
of tumor immune checkpoint control by RNF5, and (iii) establish the physiological significance and impact of
RNF5 control of microbiome and immune checkpoint on melanomagenesis in different mouse strains, age, and
under select combination therapies. Our highly integrated studies will define the fundamental mechanisms that
underlie the regulation of both gut microbiome and immune checkpoints, thereby providing new insights into
therapeutic modalities for melanoma and other cancers.
项目摘要
该应用程序旨在定义一种控制肠道微生物的新机制-免疫检查点
泛素连接酶RNF 5的相互作用,以及这种调节对黑色素瘤发展的影响
和对治疗的反应尽管在临床管理方面取得了最令人兴奋和重大的进展,
黑色素瘤通过免疫检查点为基础的临床试验,其控制机制,
对不同疗法的敏感性(或不敏感)是尚未解决的基本问题之一。在这里,
我们提供的数据支持了一个模型,即免疫检查点受肠道微生物组的调节,
由泛素连接酶RNF 5定义。我们发现Braf/Pten突变型黑色素瘤的生长受损,
与同窝出生的Rnfwt小鼠相比,同基因Rnf 5-/-小鼠与增强的肿瘤浸润有关,
肿瘤中的浸润性淋巴细胞(TIL)(CD 4和CD 8阳性)、巨噬细胞和树突状细胞,
在Rnf 5-/-小鼠中发展明显较慢。引人注目的是,共同圈养Rnf 5-/-和Rnfwt动物或
肠道微生物群的抗生素消融导致上述表型的丧失-肿瘤生长不再是
减毒的和基于免疫检查点的表型大量丢失。肠道微生物组评估
揭示了细菌物种的不同子集,其将Rnf 5-/-小鼠与其WT同窝出生的小鼠区分开(所有
“纯的”内部维持的C57 BL/6菌株)。值得注意的是,不同RNF 5-微生物组的共同点是细菌
产生选择的短链脂肪酸子集的物种。这些观察为以下方面提供了基础:
我们假设RNF 5控制影响免疫检查点的肠道微生物群,
这反过来又会影响黑色素瘤的发展。我们建议的研究将(i)定义RNF 5
对肠道微生物组-肿瘤相互作用的影响,(ii)确定调节中的微生物组依赖性变化
肿瘤免疫检查点控制RNF 5,和(iii)建立生理意义和影响
RNF 5对不同小鼠品系、年龄和性别的黑色素瘤发生的微生物组和免疫检查点的控制
在选择的联合疗法下。我们高度综合的研究将确定基本机制,
作为肠道微生物组和免疫检查点调节的基础,从而为以下方面提供新的见解:
黑色素瘤和其他癌症的治疗方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda Mac Pherson Bradley其他文献
Linda Mac Pherson Bradley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda Mac Pherson Bradley', 18)}}的其他基金
Targeting Checkpoint Inhibition in Anti-Tumor Responses
抗肿瘤反应中针对检查点抑制
- 批准号:
10202111 - 财政年份:2021
- 资助金额:
$ 60.36万 - 项目类别:
Targeting Checkpoint Inhibition in Anti-Tumor Responses
抗肿瘤反应中针对检查点抑制
- 批准号:
10372199 - 财政年份:2021
- 资助金额:
$ 60.36万 - 项目类别:
Regulation of CD4+ T cell responses during chronic viral infection
慢性病毒感染期间 CD4 T 细胞反应的调节
- 批准号:
10197841 - 财政年份:2020
- 资助金额:
$ 60.36万 - 项目类别:
Regulation of CD4+ T Cell Responses During Chronic Viral Infection
慢性病毒感染期间 CD4 T 细胞反应的调节
- 批准号:
10322954 - 财政年份:2020
- 资助金额:
$ 60.36万 - 项目类别:
Frontiers in Fundamental and Translational Immunology
基础和转化免疫学前沿
- 批准号:
10318101 - 财政年份:2018
- 资助金额:
$ 60.36万 - 项目类别:
Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
- 批准号:
10098006 - 财政年份:2017
- 资助金额:
$ 60.36万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 60.36万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 60.36万 - 项目类别:
Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
- 批准号:
9302010 - 财政年份:2017
- 资助金额:
$ 60.36万 - 项目类别:
PSGL-1, a New Player in the Immune Checkpoint Landscape
PSGL-1,免疫检查点领域的新参与者
- 批准号:
9312782 - 财政年份:2016
- 资助金额:
$ 60.36万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 60.36万 - 项目类别:
Research Grant